1. Home
  2. CCCC vs KGEI Comparison

CCCC vs KGEI Comparison

Compare CCCC & KGEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCCC
  • KGEI
  • Stock Information
  • Founded
  • CCCC 2015
  • KGEI 2008
  • Country
  • CCCC United States
  • KGEI United States
  • Employees
  • CCCC N/A
  • KGEI N/A
  • Industry
  • CCCC Biotechnology: Pharmaceutical Preparations
  • KGEI
  • Sector
  • CCCC Health Care
  • KGEI
  • Exchange
  • CCCC Nasdaq
  • KGEI Nasdaq
  • Market Cap
  • CCCC 244.9M
  • KGEI 262.6M
  • IPO Year
  • CCCC 2020
  • KGEI N/A
  • Fundamental
  • Price
  • CCCC $1.52
  • KGEI $8.58
  • Analyst Decision
  • CCCC Buy
  • KGEI Strong Buy
  • Analyst Count
  • CCCC 4
  • KGEI 1
  • Target Price
  • CCCC $12.50
  • KGEI $11.00
  • AVG Volume (30 Days)
  • CCCC 777.7K
  • KGEI 117.3K
  • Earning Date
  • CCCC 05-07-2025
  • KGEI 03-25-2025
  • Dividend Yield
  • CCCC N/A
  • KGEI N/A
  • EPS Growth
  • CCCC N/A
  • KGEI N/A
  • EPS
  • CCCC N/A
  • KGEI 0.50
  • Revenue
  • CCCC $35,584,000.00
  • KGEI $58,651,000.00
  • Revenue This Year
  • CCCC N/A
  • KGEI $39.41
  • Revenue Next Year
  • CCCC $36.32
  • KGEI $24.46
  • P/E Ratio
  • CCCC N/A
  • KGEI $17.16
  • Revenue Growth
  • CCCC 71.44
  • KGEI 15.91
  • 52 Week Low
  • CCCC $1.39
  • KGEI $2.85
  • 52 Week High
  • CCCC $8.08
  • KGEI $9.89
  • Technical
  • Relative Strength Index (RSI)
  • CCCC 25.37
  • KGEI 58.79
  • Support Level
  • CCCC $1.79
  • KGEI $6.57
  • Resistance Level
  • CCCC $2.28
  • KGEI $8.62
  • Average True Range (ATR)
  • CCCC 0.15
  • KGEI 0.61
  • MACD
  • CCCC -0.02
  • KGEI 0.12
  • Stochastic Oscillator
  • CCCC 14.61
  • KGEI 73.36

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.

About KGEI Kolibri Global Energy Inc. Common stock

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. Its segments include the United States, Canada and Others. The company derives a majority of its revenue from the United States.

Share on Social Networks: